Is a noradrenaline dose threshold already too late for adjunctive vasopressin initiation? Author’s reply
Intensive Care Medicine · 02.11.2026
DOI: 10.1007/s00134-026-08634-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift Intensive Care Medicine, online erschienen am 02.11.2026. Verfasst von Takaya Nakashima und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. a82282008@gmai…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. a82282008@gmail.com.
- Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan. a82282008@gmail.com.
- TXP Medical Co. Ltd, Tokyo, Japan. a82282008@gmail.com.
- Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- TXP Medical Co. Ltd, Tokyo, Japan.
- Department of Health Data Science, Graduate School of Data Science, Yokohama City University, Yokohama, Japan.
Zitieren
APA
Nakashima, T., Ichinomiya, T., Shibata, J., Goto, T., & Hara, T. (2026). Is a noradrenaline dose threshold already too late for adjunctive vasopressin initiation? Author’s reply. Intensive Care Medicine. https://doi.org/10.1007/s00134-026-08634-9
Vancouver
Nakashima T, Ichinomiya T, Shibata J, Goto T, Hara T. Is a noradrenaline dose threshold already too late for adjunctive vasopressin initiation? Author’s reply. Intensive Care Medicine. 2026. doi:10.1007/s00134-026-08634-9
BibTeX
@article{Nakashima2026,
author = {Nakashima, Takaya and Ichinomiya, Taiga and Shibata, Junichiro and Goto, Tadahiro and Hara, Tetsuya},
title = {Is a noradrenaline dose threshold already too late for adjunctive vasopressin initiation? Author’s reply},
journal = {Intensive Care Medicine},
year = {2026},
doi = {10.1007/s00134-026-08634-9}
}
EUVIMED